One drug isnt better than the other, but semaglutide (the active ingredient in Wegovy and Ozempic) targets a single potent pathway (the GLP-1 receptor), while retatrutide is a triple-agonist, acting on GLP-1, GIP, and glucagon receptors
Specialist hepatologists may occasionally prescribe off-label in exceptional circumstances, particularly for patients with biopsy-proven NASH and significant fibrosis, but this is not routine practice
While ColonBroom does not claim to replace medical treatment, it positions itself as a safe, natural option for those seeking better appetite control and digestive balance
Seguridad: hemograma, funcin heptica/renal, no se ha establecido toxicidad significativa hasta 1000 dosis efectiva en estudios subcrnicos